SCHEMBL1209541

SCHEMBL1209541

CC(CC(=O)Nc1sc2c(c1C#N)CCC(COC(=O)NCc1ccno1)C2)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.43
KDM4E B2RXH2 4/20 0.42
HSD17B10 Q99714 2/20 0.42
HTT P42858 1/20 0.42
MAPT P10636 8/20 0.42
GAA P10253 1/20 0.41
RAB9A P51151 4/20 0.41
NPC1 O15118 3/20 0.41
POLB P06746 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
TP53 P04637 1/20 0.41
MCL1 Q07820 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
HPGD P15428 3/20 0.40
THRB P10828 1/20 0.40
RECQL P46063 1/20 0.40
PTPN5 P54829 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12895285 0.90 HPGD (0.36) ALDH1A1KDM4EHTTMAPTRAB9A
SCHEMBL1209532 0.90 ALDH1A1 (0.42) ALDH1A1KDM4EHSD17B10HTTMAPT
SCHEMBL1209762 0.88 ALDH1A1 (0.45) ALDH1A1HTTMAPTGAARAB9A
SCHEMBL1208714 0.88 ALDH1A1 (0.45) ALDH1A1HTTMAPTGAARAB9A
SCHEMBL1207159 0.88 ALDH1A1 (0.51) ALDH1A1KDM4EHSD17B10HTTMAPT
SCHEMBL1208660 0.87 ALDH1A1 (0.43) ALDH1A1KDM4EHSD17B10HTTMAPT
SCHEMBL1209262 0.86 L3MBTL1 (0.49) ALDH1A1KDM4EMAPTGAARAB9A
SCHEMBL1209195 0.86 ALDH1A1 (0.43) ALDH1A1KDM4EHSD17B10HTTMAPT
SCHEMBL1207170 0.85 ALDH1A1 (0.43) ALDH1A1HTTMAPTGAARAB9A
SCHEMBL1207887 0.85 ALDH1A1 (0.44) ALDH1A1KDM4EHSD17B10HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES NYCOMED GMBH (DE) 2011-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES BAX, BCL2, BAD ALDH1A1 316/4885KDM4E 2054/4885HSD17B10 1786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.